CBX3在肺腺癌中的表达、预后相关性及对癌细胞生物学行为的影响

侯清华; 钟燕凤; 刘林壮; 吴柳盛; 刘继先

doi:10.19401/j.cnki.1007-3639.2022.02.007

您当前的位置：

首页 >

文章列表页 >

CBX3在肺腺癌中的表达、预后相关性及对癌细胞生物学行为的影响

论著 | 更新时间：2025-12-31

- CBX3在肺腺癌中的表达、预后相关性及对癌细胞生物学行为的影响
- Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells
- 中国癌症杂志 2022年32卷第2期页码：152-160
- 作者机构：
  
  1. 潍坊医学院临床医学院,山东潍坊 261053
  2. 北京大学深圳医院胸外科,广东深圳 518036
  3. 北京大学深圳医院中心实验室,广东深圳 518036
- 作者简介：
  
  LIU Jixian E-mail: 252110465@qq.com
- 基金信息：
  
  深圳市科技计划项目(JCYJ20180228175531145);北京大学-密歇根大学JI项目(2019020（PUSH）-r1);深圳华大生命科学研究院开放基金(BGIRSZ20200003)
- DOI：10.19401/j.cnki.1007-3639.2022.02.007
  中图分类号： R734.2
- 收稿：2021-11-28，
  
  纸质出版：2022-02-28
- 稿件说明：
移动端阅览
侯清华, 钟燕凤, 刘林壮, 等. CBX3在肺腺癌中的表达、预后相关性及对癌细胞生物学行为的影响[J]. 中国癌症杂志, 2022,32(2):152-160.

Qinghua HOU, Yanfeng ZHONG, Linzhuang LIU, et al. Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells[J]. China Oncology, 2022, 32(2): 152-160.
侯清华, 钟燕凤, 刘林壮, 等. CBX3在肺腺癌中的表达、预后相关性及对癌细胞生物学行为的影响[J]. 中国癌症杂志, 2022,32(2):152-160. DOI： 10.19401/j.cnki.1007-3639.2022.02.007.

Qinghua HOU, Yanfeng ZHONG, Linzhuang LIU, et al. Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells[J]. China Oncology, 2022, 32(2): 152-160. DOI： 10.19401/j.cnki.1007-3639.2022.02.007.

摘要

背景与目的：

作为异染色质重要组分的染色体盒3（chromobox 3

CBX3）参与多种癌症的发生、发展过程

而

CBX

3基因在肺腺癌中的表达情况和作用尚不清楚。探讨CBX3在肺腺癌中的表达与肺腺癌患者预后的关系

并研究CBX3对A549肺腺癌细胞增殖、迁移和侵袭能力的影响。

方法：

下载癌症基因组图谱（The Cancer Genome Atlas

TCGA）中的肺腺癌转录组数据和对应的临床数据

应用R软件分析CBX3在肺腺癌中的表达差异和免疫浸润相关性

采用受试者工作特征（receiver operating characteristic

ROC）曲线和Kaplan-Meier分析CBX3在肺腺癌中的预后意义;收集北京大学深圳医院智能化生物样本库-80 ℃新鲜冻存的2020年8月

#x02014;2021年1月行肺癌姑息性切除术或根治性切除术的肺腺癌样本20例（已获得知情同意）

采用实时荧光定量聚合酶链反应（real-time fluorescent quantitative polymerase chain reaction

RTFQ-PCR）检测20例冻存的肺腺癌组织及配对正常肺组织中CBX3的表达;应用小干扰RNA（siRNA）转染A549细胞以沉默CBX3的表达

并根据siRNA转染的类型将A549细胞分为沉默组（si-CBX3组）和阴性对照组（si-NC组）

通过用细胞计数试剂盒（cell counting kit-8

CCK-8）实验、克隆形成实验、划痕实验和transwell实验分别研究CBX3对A549肺腺癌细胞增殖、迁移和侵袭能力的影响。

结果：

基于TCGA肺腺癌数据的差异分析与采集的肺腺样本RTFQ-PCR实验的结果显示

CBX3在肺腺癌中呈显著的高表达

差异有统计学意义（

0.05）;辅助型T细胞2的浸润与CBX3表达呈正相关

Abstract

Background and purpose:

Chromobox 3 (CBX3)

an important component of chromatin

is involved in the development and progression of various cancers. However

the expression and role of CBX3 in lung adenocarcinoma are still unclear. This study aimed to investigate the relationship between the expression of CBX3 in lung adenocarcinoma and prognosis of lung adenocarcinoma

and to study the effects of CBX3 on proliferation

migration and invasion of A549 lung adenoca

rcinoma cells.

Methods:

Transcriptome data of lung adenocarcinoma and corresponding clinical data were downloaded from the Cancer Genome Atlas (TCGA)

and R software was used to analyze the expression difference of CBX3 and the correlation of immune infiltration in lung adenocarcinoma. The prognostic significance of CBX3 in lung adenocarcinoma was analyzed by receiver operating characteristic (ROC) curve and Kaplan-Meier analysis. Twenty lung adenocarcinoma samples from patients (with informed consent obtained) who underwent palliative or radical lung cancer resection from August 2020 to January 2021 were collected from the intelligent Biobank of Peking University Shenzhen Hospital at -80 ℃. Real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) was used to verify the expression of CBX3 in 20 frozen lung adenocarcinoma tissue samples and paired normal lung tissues. A549 cells were transfected with small interfering RNA (siRNA) to silence the expression of CBX3

and A549 cells were divided into silent group (si-CBX3 group) and negative control group (si-NC group) according to the type of siRNA transfection. The effects of CBX3 on proliferation

migration and invasion of A549 cells were investigated by cell counting kit-8 (CCK-8) assay

clone formation assay

scratch assay and transwell assay

respectively.

Results:

The difference analysis based on TCGA lung adenocarcinoma data and RTFQ-PCR results of lung adenocarcinoma samples showed that CBX3 was significantly overexpressed in lung adenocarcinoma (

0.05). The infiltration of T helper 2 (Th2) cells was positively correlated with the expression of CBX3 [correlation coefficient (

)=0.437

]

while mast cells (

=-0.444)

eosinophils (

=-0.380) and other immune cells were negatively correlated with the expression of CBX3. The area under ROC curve (AUC) value was 0.912

indicating that CBX3 has a good diagnostic value for lung adenocarcinoma. Kaplan-Meier a

nalysis showed that the survival period of the group with high expression of CBX3 was shorter

suggesting a poor prognosis. After the expression of CBX3 was silenced in A549 cells

significantly decreased proliferation ability of A549 cells was detected by CCK-8 and clone formation assays (

0.01). The results of scratch assay showed that the mobility of A549 cells was (22.68

#x000b1;3.44)% after silencing

which was significantly lower compared with the control group (

0.05). Transwell assay results showed that the relative invasion rate of A549 cells was (53.94

#x000b1;5.39)%

and the invasion ability was significantly decreased (

0.01).

Conclusion:

CBX3 is significantly overexpressed in lung adenocarcinoma

which predicts poor prognosis of lung adenocarcinoma and can be used as a prognostic marker of lung adenocarcinoma

and the high expression of CBX3 promotes the proliferation

migration and invasion of A549 cells.

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .

HUTCHINSON B D , SHROFF G S , TRUONG M T , et al . Spectrum of lung adenocarcinoma [J ] . Semin Ultrasound CT MR , 2019 , 40 ( 3 ): 255 - 264 .

ETTINGER D S , WOOD D E , AISNER D L , et al . Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology [J ] . J Natl Compr Canc Netw , 2017 , 15 ( 4 ): 504 - 535 .

OSMANI L , ASKIN F , GABRIELSON E , et al . Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy [J ] . Semin Cancer Biol , 2018 , 52 ( Pt 1 ): 103 - 109 .

XING P Y , WANG S Z , WANG Q , et al . Efficacy of crizotinib for advanced ALK-rearranged non-small cell lung cancer patients with brain metastasis: a multicenter, retrospective study in China [J ] . Target Oncol , 2019 , 14 ( 3 ): 325 - 333 .

王晓莉 , 葛晓松 , 刘彦魁 , 等 . EGFR/ALK/ROS1三联检测在非小细胞肺癌中的临床意义 [J ] . 临床与实验病理学杂志 , 2018 , 34 ( 10 ): 1135 - 1137 .

WANG X L , GE X S , LIU Y K , et al . Clinical significance of EGFR/ALK/ros1 triple detection in non-small cell lung cancer [J ] . Chin J Clin Exp Pathol , 2018 , 34 ( 10 ): 1135 - 1137 .

PARK J Y , JANG S H . Epidemiology of lung cancer in Korea: recent trends [J ] . Tuberc Respir Dis (Seoul) , 2016 , 79 ( 2 ): 58 - 69 .

TESTA U , CASTELLI G , PELOSI E . Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells [J ] . Cancers (Basel) , 2018 , 10 ( 8 ): E248 .

CHANG S C , LAI Y C , CHEN Y C , et al . CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer [J ] . Asia Pac J Clin Oncol , 2018 , 14 ( 5 ): e283 - e288 .

CANZIO D , LARSON A , NARLIKAR G J . Mechanisms of functional promiscuity by HP1 proteins [J ] . Trends Cell Biol , 2014 , 24 ( 6 ): 377 - 386 .

LOVE M I , HUBER W , ANDERS S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 [J ] . Genome Biol , 2014 , 15 ( 12 ): 550 .

HÄNZELMANN S , CASTELO R , GUINNEY J . GSVA: gene set variation analysis for microarray and RNA-seq data [J ] . BMC Bioinformatics , 2013 , 14 : 7 .

BINDEA G , MLECNIK B , TOSOLINI M , et al . Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer [J ] . Immunity , 2013 , 39 ( 4 ): 782 - 795 .

CHALELA R , CURULL V , ENRÍQUEZ C , et al . Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy [J ] . J Thorac Dis , 2017 , 9 ( 7 ): 2142 - 2158 .

IMAI H , KAIRA K , MINATO K . Clinical significance of post-progression survival in lung cancer [J ] . Thorac Cancer , 2017 , 8 ( 5 ): 379 - 386 .

GREWAL S I , JIA S . Heterochromatin revisited [J ] . Nat Rev Genet , 2007 , 8 ( 1 ): 35 - 46 .

VAKOC C R , MANDAT S A , OLENCHOCK B A , et al . Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin [J ] . Mol Cell , 2005 , 19 ( 3 ): 381 - 391 .

MATEESCU B , BOURACHOT B , RACHEZ C , et al . Regulation of an inducible promoter by an HP1beta-HP1gamma switch [J ] . EMBO Rep , 2008 , 9 ( 3 ): 267 - 272 .

KWON S H , WORKMAN J L . HP1c casts light on dark matter [J ] . Cell Cycle , 2011 , 10 ( 4 ): 625 - 630 .

NONAKA N , KITAJIMA T , YOKOBAYASHI S , et al . Recruitment of cohesin to heterochromatic regions by Swi6/HP1 in fission yeast [J ] . Nat Cell Biol , 2002 , 4 ( 1 ): 89 - 93 .

YAMAGISHI Y , SAKUNO T , SHIMURA M , et al . Author correction: heterochromatin links to centromeric protection by recruiting shugoshin [J ] . Nature , 2018 , 563 ( 7730 ): E21 .

HAYAKAWA T , HARAGUCHI T , MASUMOTO H , et al . Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase [J ] . J Cell Sci , 2003 , 116 ( Pt 16 ): 3327 - 3338 .

EGUCHI T , CALDERWOOD S K , TAKIGAWA M , et al . Intracellular MMP3 promotes HSP gene expression in collaboration with chromobox proteins [J ] . J Cell Biochem , 2017 , 118 ( 1 ): 43 - 51 .

FAN Y , LI H P , LIANG X L , et al . CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle [J ] . Oncotarget , 2017 , 8 ( 12 ): 19934 - 19946 .

WANG S Q , LIU F , WANG Y H , et al . Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma [J ] . J Transl Med , 2019 , 17 ( 1 ): 179 .

HAN S S , KIM W J , HONG Y , et al . RNA sequencing identifies novel markers of non-small cell lung cancer [J ] . Lung Cancer , 2014 , 84 ( 3 ): 229 - 235 .

LIU J , ZHANG Y , ZHAO J , et al . Mast cell: insight into remodeling a tumor microenvironment [J ] . Cancer Metastasis Rev , 2011 , 30 ( 2 ): 177 - 184 .

HUANG B , LEI Z , ZHANG G M , et al . SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment [J ] . Blood , 2008 , 112 ( 4 ): 1269 - 1279 .

浏览量

1073

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

腺癌与其他类型非小细胞肺癌术后临床特点的差异及预后因素分析

SMARCA4缺失型肺恶性肿瘤的临床病理学特征及患者预后分析

87例唾液腺导管癌患者的治疗策略与预后分析：一项回顾性队列研究

放射性淋巴细胞减少对局限期小细胞肺癌患者预后的影响：一项队列研究

肢端型黑色素瘤组织中MITF的表达及其与临床、病理学特征及预后的相关性研究